Concurrent Inhibition of the RAS-MAPK Pathway and PIKfyve is a Therapeutic Strategy for Pancreatic Cancer

已取消 10 由大老王发布于 2025/2/15 9:06:40

DOI:10.1158/0008-5472.can-24-1757
作者：Jonathan M. DeLiberty, Mallory K. Roach, Clint A. Stalnecker, Ryan Robb, Elyse G. Schechter, Noah L. Pieper, Khalilah E. Taylor, Lily M. Pita, Runying Yang, Scott Bang, Kristina Drizyte-Miller, Sarah
文献类型：期刊论文
补充材料：只需要正文
管理员驳回:超时未应助，系统关闭。如求助信息不完整（标题、DOI、原文链接），可以补充后重新发布求助。

American Association for Cancer Research (AACR)

Abstract：Pancreatic ductal adenocarcinoma (PDAC) is characterized by KRAS- and autophagy-dependent growth. Inhibition of the KRAS-RAF-MEK-ERK pathway enhances autophagic flux and dependency, and conc

应助信息

2025-02-15

Book学术机器人

2025/2/15 9:06:40 未找到该文献，机器人已退出，请等待人工下载

2025/2/15 9:06:40 Book学术AI机器人收到请求，开始寻找文献

2025/2/15 9:06:40 已向机器人发送请求

2025-02-15

大老王发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:NatureTargeting vaccines to dendritic cells by mimicking the processing and presentation of antigens in xenotransplant rejection